Expo Hub
EANM 2025
Discover our news in Nuclear Medicine.
We look forward to seeing you at EANM 2025 in
Barcelona, Spain!
We invite you to visit booths #31 and #35 to explore the future of molecular imaging with Siemens Healthineers. Connect with our experts, join innovation talks, and engage in interactive demonstrations that bring our latest breakthroughs to life. Be the first to hear about the expansion of our Biograph Trinion high-performance PET/CT platform to more users and patients. Experience the debut of BIOGRAPH One1—our new PET/MR scanner, which redefines patient-centric care. Learn more about Symbia Pro.specta theranostics edition and Biograph Vision Quadra, our large axial field-of-view (LAFOV) PET/CT.
Discover how molecular imaging is also advancing the fight against Alzheimer’s disease, enabling earlier and more precise diagnosis and monitoring therapy effectiveness to support better patient outcomes. Experience how our integrated value chain continues to strengthen theranostics programs with precision oncology solutions across the entire care pathway. See how PETNET Solutions Inc, a Siemens Healthineers Company and Advanced Accelerator Applications, a Siemens Healthineers Company are joining forces to further expand access to radiopharmaceuticals and drive innovation worldwide. Gain first-hand insights on syngo.via AI-powered reading solutions and explore how we are shaping the future of molecular imaging.
The future of molecular imaging is here—join us in shaping it.
Congress information
Date: October 4-8, 2025
Location: Barcelona, Spain
Venue: International Barcelona Convention Center (CCIB)
Booths: #31 and #35
Join us for innovative in-booth activities
EANM 2025 Satellite Symposium
1:15 pm –2:45 pm, Sunday, October 5
Room: 111
Changing the care paradigm
Emerging radiopharmaceuticals and novel therapies are increasing the demand for molecular imaging. Simultaneously, advancements in hybrid imaging are unlocking new levels of possibility.
Join us for a series of talks on how clinical teams are utilizing technology to reimagine their approach to patient care. Physicians from three renowned institutions will highlight strategies for leveraging innovations in SPECT/CT, PET/CT, and PET/MR to embrace change and lead the way.
Presentation recordings will be available online following EANM.
Product highlights
Learn more about our product highlights at EANM 2025.
Don't miss our on-demand videos
1 / 0
PET amyloid imaging in clinical trials
Dr. Jacob Dubroff reviews the current state of new treatments for Alzheimer’s, with an emphasis on how advanced imaging techniques are critical to both diagnosing the disease early and monitoring treatment responses.
Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease
Dr. Jana Ivanidze discusses the latest developments in PET tracers and PET imaging, highlighting their role in early diagnosis.
Empowering precision oncology
Expanding access to next-generation theranostics
A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics
Dr. Ryan Avery shares his expertise and best practices about utilizing PET/CT as a diagnostic tool to appropriately select patients for theranostics treatments.
The exploration of ultra-low dose PET/CT and its implications for patient care
Dr. Eliot Siegel, MD explores the clinical utility of ultra-low dose PET/CT and its implications for patient care.
See our complete portfolio
Nuclear Medicine News & Stories
Your resource for the latest news, stories, and clinical cases in nuclear medicine and molecular imaging.
Biograph Vision Quadra News & Stories
In this special edition of Nuclear Medicine News & Stories, deepen the dimension of your investigations, explore new research questions, and identify the best clinical approach for your patients with Biograph Vision Quadra.
We look forward to seeing you at EANM 2025 in Barcelona, October 4 -8, 2025.
1BIOGRAPH One is currently under development and not commercially available. It’s not for sale in the U.S.A. Its future availability cannot be ensured.
Biograph Trinion, Biograph Vision Quadra, and Symbia Pro.specta are not commercially available in all countries. Future availability cannot be guaranteed.